Search Within

Michael David Offin

  1. "Body Imaging Service"
Formats
  1. Journal Article (16)
  2. Meeting Abstract (15)
  3. Correspondence (1)
Groups
  1. Body Imaging Service (32)
  2. Department of Medicine (32)
  3. Radiology, Department of (32)
  4. Solid Tumor Oncology Division (32)
  5. Thoracic Oncology (32)
  6. Weinberg Fellows (32)

More Groups

People
  1. Michelle Ginsberg (21)
  2. Charles Rudin (20)
  3. Bob Li (18)
  4. Mark Kris (18)
  5. Alexander Drilon (16)
  6. Maria Arcila (12)

More People

Years
  1. 2025 (1)
  2. 2024 (8)
  3. 2023 (4)
  4. 2022 (5)
  5. 2021 (3)
  6. 2020 (1)

More Years

Publications
  1. Journal of Clinical Oncology (12)
  2. Journal of Thoracic Oncology (4)
  3. Clinical Cancer Research (3)
  4. JCO Precision Oncology (3)
  5. Annals of Oncology (2)
  6. JTO Clinical and Research Reports (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (15)
  2. Elsevier Inc. (6)
  3. American Association for Cancer Research (3)
  4. Elsevier BV (2)
  5. Nature Publishing Group (2)
  6. Oxford University Press (2)

More Publishers

Results (32)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • MET exon 14-altered lung cancers and MET inhibitor resistance
    Journal Article

    Guo, R.; Offin, M.; Brannon, A. R.; Chang, J.; Chow, A.; Delasos, L.; Girshman, J.; Wilkins, O.; McCarthy, C. G.; Makhnin, A.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Early ctDNA response assessment for prediction of platinum sensitivity in small cell lung cancer
    Meeting Abstract

    Murciano-Goroff, Y. R.; Hui, A. B.; Chabon, J. J.; Moding, E. J.; Lebow, E. S.; Araujo, J. A.; Isbell, J. M.; Jones, D. R.; Ginsberg, M. S.; Myers, M. L.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Efficacy of ramucirumab and docetaxel given either before or after immune checkpoint inhibitors in patients with lung cancers
    Meeting Abstract

    Offin, M.; Xu, C.; Jain, H.; Makhnin, A.; Hayes, S. A.; Plodkowski, A. J.; Halpenny, D.; Rudin, C. M.; Kris, M. G.; Drilon, A. E.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Ado-trastuzumab emtansine in patients with HER2 amplified salivary gland cancers (SGCs): Results from a phase II basket trial
    Meeting Abstract

    Li, B. T.; Shen, R.; Offin, M.; Buonocore, D. J.; Myers, M. L.; Venkatesh, A.; Razavi, P.; Ginsberg, M. S.; Ulaner, G. A.; Solit, D. B.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Acquired MET exon 14 alteration drives secondary resistance to epidermal growth factor receptor tyrosine kinase inhibitor in EGFR-mutated lung cancer
    Journal Article

    Suzawa, K.; Offin, M.; Schoenfeld, A. J.; Plodkowski, A. J.; Odintsov, I.; Lu, D.; Lockwood, W. W.; Arcila, M. E.; Rudin, C. M.; Drilon, A.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Acquired BRAF rearrangements induce secondary resistance to EGFR therapy in EGFR-mutated lung cancers
    Journal Article

    Vojnic, M.; Kubota, D.; Kurzatkowski, C.; Offin, M.; Suzawa, K.; Benayed, R.; Schoenfeld, A. J.; Plodkowski, A. J.; Poirier, J. T.; Rudin, C. M.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • A multi-histology basket trial of ado-trastuzumab emtansine in patients with HER2 amplified cancers
    Meeting Abstract

    Li, B. T.; Makker, V.; Buonocore, D. J.; Offin, M. D.; Olah, Z. T.; Panora, E.; Shen, R.; Ho, A. L.; Yaeger, R.; Iyer, G.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • PD-L1 expression, tumor mutation burden and response to immune checkpoint blockade in patients with HER2-mutant lung cancers
    Meeting Abstract

    Lai, W. C. V.; Feldman, D. L.; Buonocore, D. J.; Brzostowski, E. B.; Rizvi, H.; Plodkowski, A. J.; Ni, A.; Sabari, J. K.; Offin, M. D.; Kris, M. G.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Acquired ALK and RET gene fusions as mechanisms of resistance to osimertinib in EGFR-mutant lung cancers
    Journal Article

    Offin, M.; Somwar, R.; Rekhtman, N.; Benayed, R.; Chang, J. C.; Plodkowski, A.; Lui, A. J. W.; Eng, J.; Rosenblum, M.; Li, B. T.; more...
    JCO Precision Oncology (2018)

    Fulltext@MSK | Save
  • Molecular and imaging predictors of response to ado-trastuzumab emtansine in patients with HER2 mutant lung cancers: An exploratory phase 2 trial
    Meeting Abstract

    Li, B.; Offin, M.; Hembrough, T.; Cecchi, F.; Shen, R.; Olah, Z.; Panora, E.; Myers, M.; Brzostowski, E.; Buonocore, D.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save